|
V.SBM
|
Providing different strengths for a Cosmetic Ingredient is not substantial...
|
|
V.SBM
|
The NR's this quarter should of generated more volumes. I am wondering if...
|
|
V.SBM
|
Those that dump shares don't advertise their intentions by placing shares...
|
|
V.SBM
|
Has it been two weeks since you said we need to look back and re-evaluate?
|
|
V.SBM
|
That NR is over a year old, the consultant was engaged to fastrack Japanese...
|
|
V.SBM
|
SAN FRANCISCO, April 16, 2018 /PRNewswire/ -- Rodan & Fields, LLC (Rodan ...
|
|
V.SBM
|
In the next 6 months, Maybe 1 & 4 & (11) [Another Placement] and (12)...
|
|
V.SBM
|
I have been visiting the cosmetic retail centres here in Paris and Bordeaux...
|
|
V.SBM
|
/ R E A P E A T... (maybe the markets didn't hear the first time
|
|
V.SBM
|
Its a real issue. Up to 40% prescription drugs sold in South America are...
|
|
V.SBM
|
The new local China hire is a smart move and hopefully quality control is...
|
|
V.KNE
|
Signed deals with established distribution neworks, cash in the bank...
|
|
V.SBM
|
Well, we are a month into Q4 and should be due for rhat surprise announcement...
|
|
V.SBM
|
I was hoping to see a bit more details from R + F yesterday, based on the NR....
|
|
V.SBM
|
I saw the options exercises on Sedar, they were purchased-but not I do not...
|
|
V.KNE
|
Dechra's expansion of the licensing agreement suggests Kane's...
|
|
V.SBM
|
By ignoring you...
|
|
V.SBM
|
yep. its funny how the stated volumes don't reflect the actuals, must be...
|
|
V.SBM
|
As HCD said, the .47 resistance is very real. Someone just unloaded 200k...
|
|
V.SBM
|
Now we know the extra results from the trial, (sustained rigorous effect of...
|